Results 111 to 120 of about 513,178 (237)

Antiphospholipid antibodies and antiphospholipid syndrome [PDF]

open access: yes
Individuals with antiphospholipid syndrome (APS) have antibodies directed against phospholipid-binding proteins (aPL). The condition is most associated with an increased risk of thromboembolism and obstetric complications.
Hansen, Rasmus Søgaard   +4 more
core   +1 more source

A Paradoxical Case of Bleeding and Clots: The Hidden Thrombotic Threat in Immune Thrombocytopenic Purpura

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Immune thrombocytopenic purpura (ITP) is typically characterized by mucocutaneous bleeding, yet paradoxical thrombotic events are increasingly recognized, particularly in patients treated with thrombopoietin‐receptor agonists (TPO‐RAs) such as eltrombopag.
Nayon Kumar Sarker   +4 more
wiley   +1 more source

Antiphospholipid antibodies in cerebral ischemia.

open access: yes, 1991
In a 2-year prospective study of 146 patients with cerebral ischemia, we compared vascular risk factors for stroke with clinical and laboratory findings, particularly antiphospholipid antibodies.
A Codina   +5 more
core   +1 more source

Reversible High‐Degree Atrioventricular Block Associated With Magnesium Toxicity in Severe Pre‐Eclampsia

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 5, September 2026.
Standard‐dose magnesium sulfate may cause life‐threatening hypermagnesemia and reversible hig ‐degree atrioventricular block in pregnant women with acute kidney injury. Prompt recognition, discontinuation of magnesium sulfate, and intravenous calcium gluconate can rapidly restore cardiac conduction and improve maternal and neonatal outcomes.
Alex F. Lwiza   +5 more
wiley   +1 more source

Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus

open access: yes, 2018
Objectives: The aim of this study was to investigate the association between antiphospholipid antibodies and non-thrombotic and non-gestational manifestations of systemic lupus erythematosus.
Kınıklı, Gülay
core   +1 more source

Antiphospholipid antibodies and stroke in Down syndrome

open access: yes, 2015
Two patients with Down syndrome and the primary antiphospholipid antibody are described. One patient had a vasculopathy similar to that previously described as Moyamoya.
O'Neil, R   +3 more
core   +1 more source

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH‐AHA‐EMI Study

open access: yesHaemophilia, Volume 32, Issue 5, Page 1188-1199, September/October 2026.
ABSTRACT Introduction The GTH‐AHA‐EMI study showed that emicizumab reduces bleeding in patients with acquired haemophilia A (AHA). However, 22 clinically relevant new bleeds (CRNB) occurred in 14 of the 47 study patients, most of which required haemostatic treatment.
Halet Türkantoz   +11 more
wiley   +1 more source

FREQUENCY OF ANTIPHOSPHOLIPID SYNDROME IN DEEP VEIN THROMBOSIS

open access: yesPakistan Armed Forces Medical Journal, 2008
Objectives: To determine the frequency of antiphospholipid syndrome in patients of DVT. Study Design: Single center descriptive study. Place and Duration: It was carried out at Military Hospital Rawalpindi, from May to Oct 2003.
Omar Ahsan   +3 more
doaj   +2 more sources

Mapping the Altered Landscape of TCR Repertoire in Autoimmune Diseases

open access: yesImmunological Reviews, Volume 342, Issue 1, September 2026.
ABSTRACT Autoimmune diseases arise from the breakdown of immune tolerance through complex interactions between genetic predisposition, environmental exposures, and adaptive immune responses. High‐throughput T‐cell receptor (TCR) repertoire sequencing has transformed our ability to characterize these responses, providing unprecedented insights into ...
Celine Albalaa   +3 more
wiley   +1 more source

High Dose Corticosteroids in Chronic Histiocytic Intervillositis Allowing Prolongation of Pregnancy: A Case Report

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 9, September 2026.
ABSTRACT Chronic histiocytic intervillositis (CHI) is a rare placental disorder linked to poor pregnancy outcomes, including fetal growth restriction and perinatal loss. We report a case of recurrent CHI in a 36‐year‐old woman with five previous pregnancy losses. In her sixth pregnancy, placental histology confirmed CHI after preterm delivery.
Arti Dave   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy